Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.2 was added and the previous revision v3.6.0 was removed, updating the page to reflect the new software release.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now states that it is no longer looking for participants, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with minor header adjustments (Intervention/Treatment) and a revision update (v3.6.0).SummaryDifference0.4%

- Check25 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. This does not modify the study details or publicly visible content.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 in the page footer, indicating a minor update to the page content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s interface/release revision number was updated from v3.5.2 to v3.5.3, reflecting a general maintenance/version change rather than a change to the study content.SummaryDifference0.1%

- Check74 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.